Resultados da pesquisa - Kevin Song

Refinar resultados
  1. 1
    Autologous stem cell transplant for relapsed and refractory peripheral T‐cell lymphoma: variable outcome according to pathological subtype

    Autologous stem cell transplant for relapsed and refractory peripheral T‐cell lymphoma: variable outcome according to pathological subtype Por Kevin Song, Peter Mollee, Armand Keating, Michael Crump

    Publicado em 2003
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  2. 2
    Glycan reader: Automated sugar identification and simulation preparation for carbohydrates and glycoproteins

    Glycan reader: Automated sugar identification and simulation preparation for carbohydrates and glycoproteins Por Sunhwan Jo, Kevin Song, Heather Desaire, Alexander D. MacKerell, Wonpil Im

    Publicado em 2011
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  3. 3
    SARS-COV-2 as potential microRNA sponge in COVID-19 patients

    SARS-COV-2 as potential microRNA sponge in COVID-19 patients Por Chang Li, Rebecca Wang, Aurora Wu, Tina L. Yuan, Kevin Song, Yongsheng Bai, Xiaoming Liu

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    Selective refueling of CAR T cells using ADA1 and CD26 boosts antitumor immunity

    Selective refueling of CAR T cells using ADA1 and CD26 boosts antitumor immunity Por Yue Hu, Abhijit Sarkar, Kevin Song, Sara Michael, Magnus Höök, Ruoning Wang, Andras Heczey, Xiao‐Tong Song

    Publicado em 2024
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  5. 5
    Nucleolytic processing of abasic sites underlies PARP inhibitor hypersensitivity in ALC1-deficient BRCA mutant cancer cells

    Nucleolytic processing of abasic sites underlies PARP inhibitor hypersensitivity in ALC1-deficient BRCA mutant cancer cells Por Natasha Ramakrishnan, Tyler Weaver, Lindsey N Aubuchon, Ayda Woldegerima, Taylor Just, Kevin Song, Alessandro Vindigni, Bret Freudenthal, Priyanka Verma

    Publicado em 2024
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    Nicotine behavioral pharmacology: Clues from planarians

    Nicotine behavioral pharmacology: Clues from planarians Por Scott M. Rawls, Tanvi Patil, Christopher S. Tallarida, Steven H. Baron, Myongji Kim, Kevin Song, Sara Jane Ward, Robert B. Raffa

    Publicado em 2011
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant

    Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant Por Nelson Leung, Frank Bridoux, Colin A. Hutchison, Samih H. Nasr, Paul Cockwell, Jean-Paul Fermand, Angela Dispenzieri, Kevin Song, Robert A. Kyle

    Publicado em 2012
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  8. 8
    Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation

    Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation Por Christopher Staley, Thomas Kaiser, Byron P. Vaughn, Carolyn Graiziger, Matthew J. Hamilton, Tauseef Ur Rehman, Kevin Song, Alexander Khoruts, Michael J. Sadowsky

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    CHARMM-GUI<i>Membrane Builder</i>toward realistic biological membrane simulations

    CHARMM-GUI<i>Membrane Builder</i>toward realistic biological membrane simulations Por Emilia L. Wu, Xi Cheng, Sunhwan Jo, Huan Rui, Kevin Song, Eder M. Dávila-Contreras, Yifei Qi, Jumin Lee, Viviana Monje‐Galvan, Richard M. Venable, Jeffery B. Klauda, Wonpil Im

    Publicado em 2014
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  10. 10
    Impact of oncogene rearrangement patterns on outcomes in patients with double‐hit non‐Hodgkin lymphoma

    Impact of oncogene rearrangement patterns on outcomes in patients with double‐hit non‐Hodgkin lymphoma Por Daniel J. Landsburg, Adam M. Petrich, Jeremy S. Abramson, Aliyah R. Sohani, Oliver W. Press, Ryan D. Cassaday, Julio C. Chávez, Kevin Song, Andrew D. Zelenetz, Mitul Gandhi, Namrata Shah, Timothy S. Fenske, Jesse Jaso, L. Jeffrey Medeiros, David T. Yang, Chadi Nabhan

    Publicado em 2015
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    Patient‐reported health‐related quality of life from the phase III TOURMALINE‐MM1 study of ixazomib‐lenalidomide‐dexamethasone versus placebo‐lenalidomide‐dexamethasone in relapsed/refractory multiple myeloma

    Patient‐reported health‐related quality of life from the phase III TOURMALINE‐MM1 study of ixazomib‐lenalidomide‐dexamethasone versus placebo‐lenalidomide‐dexamethasone in relapsed... Por Xavier Leleu, Tamás Masszi, Nizar J. Bahlis, Luísa Viterbo, Bartrum Baker, Peter Gimsing, Vladimír Maisnar, Olga Samoilova, Laura Rosiñol, Christian Langer, Kevin Song, Tohru Izumi, Charles S. Cleeland, Deborah Berg, Huamao Mark Lin, Yanyan Zhu, Tomáš Skácel, Philippe Moreau, Paul G. Richardson

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  12. 12
    Pomalidomide plus low‐dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure

    Pomalidomide plus low‐dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure Por David S. Siegel, Gary J. Schiller, Kevin Song, Richy Agajanian, Keith Stockerl‐Goldstein, Hakan Kaya, Michaël Sébag, Christy Samaras, Ehsan Malek, Giampaolo Talamo, Christopher S. Seet, Jorge Mouro, William E. Pierceall, Faiza Zafar, Weiyuan Chung, Shankar Srinivasan, Amit Agarwal, Nizar J. Bahlis

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    Allogeneic haematopoietic stem‐cell transplantation for relapsed and refractory aggressive histology non‐Hodgkin lymphoma*

    Allogeneic haematopoietic stem‐cell transplantation for relapsed and refractory aggressive histology non‐Hodgkin lymphoma* Por Richard Doocey, Cynthia L. Toze, Joseph M. Connors, Thomas J. Nevill, Randy D. Gascoyne, Michael J. Barnett, Donna L. Forrest, Donna E. Hogge, Julye C. Lavoie, Stephen H. Nantel, John D. Shepherd, Heather J. Sutherland, Nicholas Voss, Clayton A. Smith, Kevin Song

    Publicado em 2005
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  14. 14
    High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver

    High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouve... Por Julye C. Lavoie, Joseph M. Connors, Gordon L. Phillips, Donna Reece, Michael J. Barnett, Donna L. Forrest, Randy D. Gascoyne, Donna E. Hogge, Stephen H. Nantel, John D. Shepherd, Clayton A. Smith, Kevin Song, Heather J. Sutherland, Cynthia L. Toze, Nicholas Voss, Thomas J. Nevill

    Publicado em 2005
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  15. 15
    Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide

    Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidom... Por Michel Delforge, Leonard Minuk, J.-C. Eisenmann, Bertrand Arnulf, Letizia Canepa, Alberto Fragasso, Serge Leyvraz, Christian Langer, Yousef Ezaydi, Dan T. Vogl, Pilar Giraldo-Castellano, S.-S. Yoon, Charles Zarnitsky, Martine Escoffre‐Barbe, Bernard Lemieux, Kevin Song, NJ Bahlis, Shu Guo, Mara Silvia Monzini, A. Ervin-Haynes, Vanessa Houck, Thierry Façon

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  16. 16
    Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment

    Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment Por David S. Siegel, Gary J. Schiller, Christy Samaras, Michaël Sébag, Jesús G. Berdeja, Siddhartha Ganguly, Jeffrey Matous, Kevin Song, Christopher S. Seet, Giampaolo Talamo, Mirelis Acosta-Rivera, Michael Bär, Donald P. Quick, Bertrand Anz, Gustavo Fonseca, Donna Reece, William E. Pierceall, Weiyuan Chung, Faiza Zafar, Amit Agarwal, Nizar J. Bahlis

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  17. 17
    Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma

    Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone... Por Jesús F. San Miguel, K. Weisel, Kevin Song, M. Delforge, Lionel Karlin, Hartmut Goldschmidt, Philippe Moreau, A. Baños, Albert Oriol, L. Garderet, Michèle Cavo, V. Ivanova, Adrián Alegre, Joaquín Martínez‐López, C. Chen, Christoph Renner, NJ Bahlis, Xiaoyan Yu, T. A. Teasdale, Lars Sternås, Christian Jacques, Mohamed H. Zaki, Meletios Α. Dimopoulos

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  18. 18
    Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma

    Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma Por Max S. Topp, Tom van Meerten, Roch Houot, Monique C. Minnema, Krimo Bouabdallah, Pieternella J. Lugtenburg, Catherine Thiéblemont, Martin Wermke, Kevin Song, Irit Avivi, John Kuruvilla, Ulrich Dührsen, Yan Zheng, Saran Vardhanabhuti, Jinghui Dong, Adrian Bot, John M. Rossi, Vicki Plaks, Marika Sherman, Jenny J. Kim, A. Kerber, Marie José Kersten

    Publicado em 2021
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  19. 19
    Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study

    Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study Por Andrzej Jakubowiak, David S. Siegel, Thomas C. Martin, M. Wang, Ravi Vij, Sagar Lonial, Suzanne Trudel, Vishal Kukreti, Nizar J. Bahlis, Melissa Alsina, Asher Chanan‐Khan, Francis K. Buadi, Frederic J. Reu, George Somlo, Jeffrey A. Zonder, Kevin Song, A. Keith Stewart, Edward A. Stadtmauer, Beverly Harrison, Alvin Wong, Robert Z. Orlowski, Sundar Jagannath

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  20. 20
    A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma

    A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma Por David S. Siegel, Thomas G. Martin, Michael Wang, Ravi Vij, Andrzej Jakubowiak, Sagar Lonial, Suzanne Trudel, Vishal Kukreti, Nizar J. Bahlis, Melissa Alsina, Asher Chanan‐Khan, Francis K. Buadi, Frederic J. Reu, George Somlo, Jeffrey A. Zonder, Kevin Song, A. Keith Stewart, Edward A. Stadtmauer, Lori Kunkel, Sandra Wear, Alvin Wong, Robert Z. Orlowski, Sundar Jagannath

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: